Opinion: STAT+: PhRMA CEO: ‘Most-favored nation’ policy isn’t the way to lower drug prices

Policymakers will need to address the true drivers of high drug prices here at home, while simultaneously pressing our allies to contribute more abroad, writes PhRMA’s Steve Ubl.